Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02316678 · ClinicalTrials.gov registry record
Patient Attitudes and Preferences for Outcomes of Inflammatory Bowel Disease Therapeutics
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 9,573
- Enrollment target
NCT02316678: Completed study, sponsored by University of Pennsylvania.
NCT02316678 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 9,573 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02316678 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 9,573 participants
- Enrollment target
Study Summary
The investigators will test the hypothesis that that greater efficacy of anti-tumor necrosis factor (antiTNF) therapy results in reduced need for bowel resection surgery, fewer serious infections, and reduced short term mortality risks, and therefore has a more favorable benefit to harm profile than corticosteroids for inflammatory bowel disease.
Primary Outcome
Incidence of death per 1000 person-years Outcome Measure Time Frame:Follow-up was from the date that the participant first met the criteria for either prolonged corticosteroid use or new anti-TNF use until either the patient died, discontinued enrollment in Medicaid or Medicare Part A, B, or D, reached age 90, was newly diagnosed with other immune-mediated diseases or AIDS, or reached the end of the available data, whichever came first, assessed up to 13 years. Follow-up of patients with UC als
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9,573 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-12 |
What the finished NCT02316678 record still lists
NCT02316678 is an observational study that tracks outcomes without assigning an intervention. Its 9,573 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT02316678 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02316678 about?
NCT02316678 is a clinical study titled "Patient Attitudes and Preferences for Outcomes of Inflammatory Bowel Disease Therapeutics". The investigators will test the hypothesis that that greater efficacy of anti-tumor necrosis factor (antiTNF) therapy results in reduced need for bowel resection surgery, fewer serious infections, and reduced short term mortality risks, and therefore has a more favorable benefit to harm profile than...
What is the current status of trial NCT02316678?
This trial is currently completed. The enrollment target is 9,573 participants. The study started on 2014-09. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02316678?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT02316678?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05080673 · 9,500 participants · NA
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- NCT06284408 · 9,460 participants · NA
Centralized Screening Unit (CSU) at Montefiore-Einstein
- NCT00160771 · 10,000 participants
Biomechanics/Motion Analysis Laboratory Data Bank
- NCT00896935 · 10,000 participants
Arizona Cancer Center Biospecimen Repository
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia